Alzheimer Disease: all 3,765 studies

Page 15 of 38. Open to participants first (881), then studies with results posted, then the rest; newest registration first within each.

• A Phase 2a Study to Evaluate the Effect of Rilapladib (SB-659032) in Alzheimer's DiseaseCompletedNCT01428453Phase 2Results posted
• Study of the Safety & Efficacy of Leukine® in the Treatment of Alzheimer's DiseaseCompletedNCT01409915Phase 2Results posted
• Cilostazol Augmentation Study in DementiaCompletedNCT01409564Phase 4Results posted
• A 24-Week Efficacy, Safety and Tolerability of Rivastigmine Patch Study in Patients With Probable Alzheimer's DiseaseCompletedNCT01399125Phase 3Results posted
• Safety Study of R(+)Pramipexole to Treat Early Alzheimer's DiseaseCompletedNCT01388478Phase 2Results posted
• [18F]MK-3328 as a Possible Novel Positron Emission Tomography (PET) Tracer for the Detection of Brain Amyloid Plaques (MK-3328-002)TerminatedNCT01385033Phase 1Results posted
• iCare Stress Management e-Training for Dementia Family CaregiversCompletedNCT01378195Phase 2Results posted
• 3-month Study of MSDC-0160 Effects on Brain Glucose Utilization, Cognition & Safety in Subjects With Alzheimer's DiseaseCompletedNCT01374438Phase 2Results posted
• Open Label Extension Study Evaluating Safety and Tolerability of AAB-003 (PF-05236812) in Subject With Mild to Moderate Alzheimer's DiseaseCompletedNCT01369225Phase 1Results posted
• Comparative Research of Alzheimer's Disease DrugsTerminatedNCT01362686Not applicableResults posted
• Safety and Efficacy Study of Ladostigil in Mild to Moderate Probable Alzheimer's DiseaseCompletedNCT01354691Phase 2Results posted
• Trial of Carvedilol in Alzheimer's DiseaseCompletedNCT01354444Phase 4Results posted
• Safety and Efficacy of ORM-12741 in Patients With Alzheimer's DiseaseCompletedNCT01324518Phase 2Results posted
• Evaluation of Safety & Tolerability of Multiple Dose Regimens of CHF 5074CompletedNCT01303744Phase 2Results posted
• A Study Versus E2020 10mg Followed by an Open-label Extension Phase to Explore the Safety of E2020 SR 23 mg in Japanese Subjects With Severe Alzheimer's Type DementiaCompletedNCT01276353Phase 2Results posted
• Effects of Strengthening Exercise on the Brain for Early Dementia and Normative Older AdultsCompletedNCT01264614Not applicableResults posted
• A Pilot Clinical Trial of Exendin-4 in Alzheimer's DiseaseTerminatedNCT01255163Phase 2Results posted
• Long Term Extension Study Evaluating Safety, Tolerability And Immunogenicity Of ACC-001 In Japanese Subjects With Mild To Moderate Alzheimer's DiseaseTerminatedNCT01238991Phase 2Results posted
• Amyloid Imaging And Safety Study Of ACC-001 In Subjects With Early Alzheimer's DiseaseCompletedNCT01227564Phase 2Results posted
• A Safety Study of LY2886721 Multiple Doses in Healthy SubjectsCompletedNCT01227252Phase 1Results posted
• A Study of Gantenerumab in Participants With Prodromal Alzheimer's DiseaseCompletedNCT01224106Phase 3Results posted
• Measuring Brain Amyloid Plaque Load in Older Adults Using BAY 94-9172CompletedNCT01222351Not applicableResults posted
• Practice Effects and Amyloid Imaging Using 18F-PIB or Flutemetamol PET and FDG-PETCompletedNCT01202994Phase 2Results posted
• Study Evaluating The Safety Of AAB-003 (PF-05236812) In Subjects With Alzheimer's DiseaseCompletedNCT01193608Phase 1Results posted
• The CIRCADIAN Study: Evaluation of Modulating Effect of Galantamine on Circadian Rhythm in Patients With Mild to Moderate Alzheimer's DiseaseTerminatedNCT01181921Phase 4Results posted
• Treatment of Apathy in Alzheimer's Disease With ModafinilCompletedNCT01172145Phase 3Results posted
• Mechanisms of Insulin Facilitation of MemoryCompletedNCT01145482Not applicableResults posted
• Effects of Simvastatin on BiomarkersCompletedNCT01142336Phase 4Results posted
• Florbetaben (BAY94-9172) PET (Positron Emission Tomography) Imaging in MCI (Mild Cognitive Impairment) PatientsCompletedNCT01138111Phase 1Results posted
• A Safety Study of LY2886721 Single Doses in Healthy SubjectsCompletedNCT01133405Phase 1Results posted
• Dose Response Study of Aerobic Exercise in Older AdultsCompletedNCT01129115Early Phase 1Results posted
• Pilot Study of Aerobic Exercise in Early Alzheimer's Disease(AD)CompletedNCT01128361Not applicableResults posted
• Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's DiseaseTerminatedNCT01127633Phase 3Results posted
• Prazosin Treatment for Disruptive Agitation in Alzheimer's DiseaseCompletedNCT01126099Not applicableResults posted
• Efficacy and Safety of Lornoxicam in Patients With Mild to Moderate Probable Alzheimer´s Disease.TerminatedNCT01117948Phase 2Results posted
• Apathy in Dementia Methylphenidate Trial (ADMET)CompletedNCT01117181Phase 2Results posted
• Quality Of Life Assessment In Alzheimer's Disease (AD) Patients Receiving Aricept TabletsCompletedNCT01089582Results posted
• Acute Effects Of Donepezil On Brain Perfusion And Memory In Subjects With Cognitive Impairment And Mild Alzheimer's DiseaseTerminatedNCT01082965Not applicableResults posted
• Alzheimer's Disease Acitretin MedicationCompletedNCT01078168Phase 2Results posted
• A Pilot Trial of Interferon Beta-1a in Alzheimer's DiseaseCompletedNCT01075763Phase 2Results posted
• An Extension To The B1451006 Protocol To Evaluate The Safety and Efficacy of Dimebon In Subjects With Moderate-to-Severe Alzheimer's DiseaseTerminatedNCT01066546Phase 3Results posted
• Lipoic Acid and Omega-3 Fatty Acids for Alzheimer's DiseaseCompletedNCT01058941Phase 1/2Results posted
• The Efficacy of Galantamine Treatment on Attention in Patients With Alzheimer's DiseaseCompletedNCT01054976Phase 4Results posted
• A Study of Semagacestat for Alzheimer's PatientsCompletedNCT01035138Phase 3Results posted
• A Study to Evaluate the Safety, Tolerability, and Blood Levels of PF-03654746 in Subjects With Mild to Moderate Alzheimer's DiseaseTerminatedNCT01028911Phase 1Results posted
• Assess the Prognostic Usefulness of Flutemetamol (18F) Injection for Identifying Subjects With Amnestic Mild Cognitive Impairment Who Will Convert to Clinically Probable Alzheimer's DiseaseCompletedNCT01028053Phase 3Results posted
• Phase III Study of Florbetaben (BAY94-9172) PET Imaging for Detection/Exclusion of Cerebral β-amyloid Compared to HistopathologyCompletedNCT01020838Phase 3Results posted
• A Long-Term Safety And Tolerability Extension Study Of Bapineuzumab In Alzheimer Disease PatientsTerminatedNCT00998764Phase 3Results posted
• Home Evaluation of Exit Barriers in WanderingCompletedNCT00997425Not applicableResults posted
• A Long-Term Safety And Tolerability Study Of Bapineuzumab In Alzheimer Disease PatientsTerminatedNCT00996918Phase 3Results posted
• A Brief Study To Evaluate The Safety, Tolerability, And Blood Levels Of Multiple Doses Of PF-044467943 Or Placebo In Combination With Donepezil In Subjects With Mild To Moderate Alzheimer's DiseaseCompletedNCT00988598Phase 1Results posted
• Studying the Effects of Antihypertensives on Individuals at Risk for Alzheimer'sCompletedNCT00980785Phase 4Results posted
• A Study To Evaluate The Abuse Potential Of Single Oral Doses Of Dimebon (Latrepirdine) In Healthy Recreational Polydrug UsersCompletedNCT00975481Phase 1Results posted
• A Long Term Extension Study Evaluating ACC-001 With QS-21 in Subjects With Mild to Moderate Alzheimer's DiseaseTerminatedNCT00960531Phase 2Results posted
• Safety, Tolerability, And Immunogenicity Study Of ACC-001 In Japanese Subjects With Mild To Moderate Alzheimer's DiseaseCompletedNCT00959192Phase 2Results posted
• Long Term Extension Study Evaluating Safety, Tolerability and Immunogenicity Of ACC-001 In Subjects With Mild To Moderate Alzheimer's DiseaseCompletedNCT00955409Phase 2Results posted
• Safety, Radiation Dosimetry, Biokinetics, and Effectiveness of [18F]MK3328 (MK-3328-001)CompletedNCT00954538Phase 1Results posted
• Effects of Rivastigmine Patch on Activities of Daily Living and Cognition in Patients With Severe Dementia of the Alzheimer's Type (ACTION) (Study Protocol CENA713DUS44, NCT00948766) and a 24 Week Open-label Extension to Study CENA713DUS44CompletedNCT00948766Phase 4Results posted
• Light Treatment for Sleep/Wake Disturbances in Alzheimer's DiseaseCompletedNCT00946530Not applicableResults posted
• A Multiple Dose Study of PF-04360365 In Patients With Mild to Moderate Alzheimer's DiseaseCompletedNCT00945672Phase 2Results posted
• Efficacy of Circadin® 2 mg in Patients With Mild to Moderate Alzheimer Disease Treated With AChE InhibitorCompletedNCT00940589Phase 2Results posted
• Statin Effects on Beta-Amyloid and Cerebral Perfusion in Adults at Risk for Alzheimer's DiseaseCompletedNCT00939822Phase 2Results posted
• An Extension To The B1451027 Protocol To Evaluate The Long Term Safety And Tolerability Of Dimebon In Patients With Alzheimer's DiseaseTerminatedNCT00939783Phase 3Results posted
• ELND005 Long-Term Follow-up Study in Subjects With Alzheimer's DiseaseCompletedNCT00934050Phase 2Results posted
• Effects of Memantine on Magnetic Resonance (MR) Spectroscopy in Subjects at Risk for Alzheimer's DiseaseCompletedNCT00933608Phase 4Results posted
• A Study Of PF-04447943 Compared To Placebo In Subjects With Mild To Moderate Alzheimer's DiseaseCompletedNCT00930059Phase 2Results posted
• Study Evaluating The Long-Term Safety And Efficacy Of Subcutaneous BapineuzumabTerminatedNCT00916617Phase 2Results posted
• A Phase 3 Efficacy Study Of Dimebon In Patients With Moderate To Severe Alzheimer's DiseaseTerminatedNCT00912288Phase 3Results posted
• Comparative Study to Test Safety and Efficacy of Neurotrophic and Cholinergic Treatment of Alzheimer's DiseaseCompletedNCT00911807Phase 2Results posted
• Citalopram for Agitation in Alzheimer's DiseaseCompletedNCT00898807Phase 3Results posted
• Study Comparing 3 Dosage Levels Of SAM-531 In Outpatients With Mild To Moderate Alzheimer DiseaseTerminatedNCT00895895Phase 2Results posted
• Non-Interventional Study With Aricept® EvessCompletedNCT00889603Results posted
• Semantic Memory, Financial Capacity, and Brain Perfusion in Mild Cognitive Impairment (MCI) (CASL)CompletedNCT00880555Results posted
• A Study to Evaluate the Effects of MK-0249 and an Alzheimer's Disease Medication on Cognitive Function in Adults With Alzheimer's Disease (MK-0249-023)TerminatedNCT00874939Phase 1Results posted
• A Clinical Study Evaluating the Effects of Memantine on Brain Atrophy in Patients With Alzheimer's DiseaseCompletedNCT00862940Phase 4Results posted
• Efficacy and Safety of Memantine in Moderate to Severe Alzheimer's DiseaseTerminatedNCT00857649Phase 3Results posted
• Observational Study of Cognitive Outcomes for Subjects Who Have Had Prior PET Amyloid Imaging With Florbetapir F 18 (18F-AV-45)CompletedNCT00857506Phase 2Results posted
• Phase III Study of the Correlation Between Florbetapir F18 PET Imaging and Amyloid Pathology in the BrainCompletedNCT00857415Phase 3Results posted
• Safety and Tolerability of Memantine in Moderate to Severe Alzheimer's DiseaseTerminatedNCT00857233Phase 3Results posted
• Ability Of ([18F]-AV-45) PET Scan to Distinguish Alzheimer's Disease Subjects From Cognitively Normal IndividualsCompletedNCT00855868Phase 2Results posted
• Treatment for Aggression and Agitation in Patients With Alzheimer's DiseaseCompletedNCT00843518Phase 2Results posted
• Observational Study Of Donepezil In Routine Clinical PracticeTerminatedNCT00843115Results posted
• A Phase 3 Study To Evaluate The Safety And Tolerability Of Dimebon Patients With Mild To Moderate Alzheimer's DiseaseCompletedNCT00838110Phase 3Results posted
• A Phase 3 Study Evaluating Safety and Effectiveness of Immune Globulin Intravenous (IGIV 10%) for the Treatment of Mild-to-Moderate Alzheimer´s DiseaseCompletedNCT00818662Phase 3Results posted
• An Efficacy and Safety Study of Galantamine for the Treatment of Patients With Alzheimer's DiseaseCompletedNCT00814801Phase 3Results posted
• Effect of Repetitive Transcranial Magnetic Stimulation on Language in Alzheimer's DiseaseCompletedNCT00814697Phase 2Results posted
• Zolpidem CR and Hospitalized Patients With DementiaCompletedNCT00814502Not applicableResults posted
• Effect of EGb761® on Brain Glucose Metabolism in Three Groups of Elderly Defined by Cognitive FunctionsCompletedNCT00814346Phase 2Results posted
• Study of Octagam (Intravenous Immunoglobulin [IVIG]) 10% on the Treatment of Mild to Moderate Alzheimer's DiseaseCompletedNCT00812565Phase 2Results posted
• A Study to Test the Performance of the CogState Computerized Neuropsychological Battery in Patients With Alzheimer's Disease (0000-086)(COMPLETED)CompletedNCT00777608Phase 1Results posted
• Safety, Tolerability, and Pharmacokinetic Study of EVP-6124 in Patients With Alzheimer's DiseaseCompletedNCT00766363Phase 1Results posted
• Effects of LY450139, on the Progression of Alzheimer's Disease as Compared With PlaceboCompletedNCT00762411Phase 3Results posted
• LifeZig Personalized Reminiscence Video With Slideshows and Music for Individuals With Alzheimer's and DementiaCompletedNCT00759863Phase 2Results posted
• Study Evaluating ACC-001 in Japanese Patients With Mild To Moderate Alzheimer's DiseaseCompletedNCT00752232Phase 2Results posted
• Phase II Study of Florbetaben (BAY 94-9172) PET Imaging for Detection/Exclusion of Cerebral β-amyloid in Patients With Probable Alzheimer's Disease Compared to Healthy VolunteersCompletedNCT00750282Phase 2Results posted
• Evaluation of the Efficacy of Varenicline on Cognition, Safety, Tolerability and Pharmacokinetics in Subjects With Mild-to-Moderate Alzheimer's DiseaseCompletedNCT00744978Phase 2Results posted
• Efficacy and Safety of Plasma Exchange With 5% Albumin in Beta-amyloid Peptide Clearance in Cerebral Spinal FluidCompletedNCT00742417Phase 2Results posted
• Multiple IV Dose Study Of PF-04360365 In Patients With Mild To Moderate Alzheimer's DiseaseCompletedNCT00722046Phase 2Results posted
• Behavioral and Neuroimaging Changes After Cognitive Rehab in Traumatic Brain Injuries (TBI) and Mild Cognitive Impairment (MCI)CompletedNCT00714571Phase 1Results posted
• A Study of SB-742457, Added to Donepezil for the Treatment of Mild-to-moderate Alzheimer's DiseaseCompletedNCT00710684Phase 2Results posted

← Alzheimer Disease overview